Compounds > imipenem, anhydrous
Page last updated: 2024-08-26

imipenem, anhydrous and Flavobacteriaceae Infections

imipenem, anhydrous has been researched along with Flavobacteriaceae Infections in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S1
Chen, CH; Lin, CH; Lin, JS1
Chang, TY; Chen, HY; Cheng, YH; Chou, YC; Sun, JR1
Diene, SM; Gupta, SK; Rolain, JM; Sharma, P1
Chen, Y; Huang, L; Kuai, S; Liu, J; Pei, H1
Huang, Y; Li, JB; Lin, XH; Sun, XH; Xu, YH1

Other Studies

6 other study(ies) available for imipenem, anhydrous and Flavobacteriaceae Infections

ArticleYear
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA

2007
Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
    Revista do Instituto de Medicina Tropical de Sao Paulo, 2017, 06-01, Volume: 59

    Topics: Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged

2017
In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Edetic Acid; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Rifampin; Species Specificity; Vancomycin

2019
Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; beta-Lactamases; Chryseobacterium; Colistin; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; France; Humans; Imipenem; Mutation; Phylogeny; Sequence Analysis, DNA

2015
Imipenem resistance due to class A carbapenemase KPC-2 in a Flavobacterium odoratum isolate.
    Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 9

    Topics: Abdominal Abscess; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; DNA, Bacterial; Flavobacteriaceae Infections; Flavobacterium; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction

2011
Genetic diversity analyses of antimicrobial resistance genes in clinical Chryseobacterium meningosepticum isolated from Hefei, China.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamases; China; Chryseobacterium; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Microbial Sensitivity Tests

2012